Pharmacy Administration

Research output

Research output per year 2019 2019 2020 2021 2022 2023 2024

• 11 Article
• 4 Review article
• 1 Chapter
• 1 Comment/debate
• 1 More
  • 1 Editorial

Research output per year

Research output per year

Search results

• 2024

  Susceptible bacteria can survive antibiotic treatment in the mammalian gastrointestinal tract without evolving resistance

  Rodrigues, M., Sabaeifard, P., Yildiz, M. S., Lyon, A., Coughlin, L., Ahmed, S., Poulides, N., Toprak, A. C., Behrendt, C., Wang, X., Monogue, M., Kim, J., Gan, S., Zhan, X., Filkins, L., Williams, N. S., Hooper, L. V., Koh, A. Y. & Toprak, E., Mar 13 2024, In: Cell Host and Microbe. 32, 3, p. 396-410.e6

  Research output: Contribution to journal › Article › peer-review

  • Cefepime 100%
  • gastrointestinal system 71%
  • Gastrointestinal Tract 64%
  • antibiotics 55%
  • Bacteria 50%
  1 Scopus citations
• 2023

  Guidelines for Diagnosis and Management of Infective Endocarditis in Adults: A WikiGuidelines Group Consensus Statement

  McDonald, E. G., Aggrey, G., Tarik Aslan, A., Casias, M., Cortes-Penfield, N., Dong, M. Q. D., Egbert, S., Footer, B., Isler, B., King, M., Maximos, M., Wuerz, T. C., Azim, A. A., Alza-Arcila, J., Bai, A. D., Blyth, M., Boyles, T., Caceres, J., Clark, D., Davar, K., & 31 othersDenholm, J. T., Forrest, G., Ghanem, B., Hagel, S., Hanretty, A., Hamilton, F., Jent, P., Kang, M., Kludjian, G., Lahey, T., Lapin, J., Lee, R., Li, T., Mehta, D., Moore, J., Mowrer, C., Ouellet, G., Reece, R., Ryder, J. H., Sanctuaire, A., Sanders, J. M., Stoner, B. J., So, J. M., Tessier, J. F., Tirupathi, R., Tong, S. Y. C., Wald-Dickler, N., Yassin, A., Yen, C., Spellberg, B. & Lee, T. C., Jul 3 2023, In: JAMA Network Open. 6, 7, p. e2326366

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Endocarditis 100%
  • Consensus 91%
  • Guidelines 61%
  • Bacterial Endocarditis 38%
  • Randomized Controlled Trials 18%
  5 Scopus citations

• Identification of Risk Factors for Intra-Abdominal Candidiasis

  Habighorst, K., Sanders, J. M., Hennessy, S. A., Goff, K., Wan, B. & Johns, M., Dec 1 2023, In: Surgical Infections. 24, 10, p. 910-915 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Candidiasis 100%
  • Upper Gastrointestinal Tract 35%
  • Peritoneal Dialysis 30%
  • Odds Ratio 27%
  • Artificial Respiration 27%

• Probable Encephalopathy and Spasticity in a Multiple Sclerosis Patient Following Carbapenem Administration: A Case Report and Brief Literature Review

  Klimko, C. V., Sanders, J. M. & Johns, M. L., Jun 2023, In: Journal of Pharmacy Practice. 36, 3, p. 699-704 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Carbapenems 100%
  • Brain Diseases 81%
  • Multiple Sclerosis 76%
  • Ertapenem 25%
  • Meropenem 21%
• 2022

  A case-control study evaluating the unnecessary use of intravenous broad-spectrum antibiotics in presumed sepsis and septic-shock patients in the emergency department

  Bae, E. Y., Smith, T. T. & Monogue, M. L., Dec 6 2022, In: Antimicrobial Stewardship and Healthcare Epidemiology. 2, 1, e193.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Septic Shock 100%
  • Bacterial Infections 90%
  • Sepsis 78%
  • Case-Control Studies 78%
  • Hospital Emergency Service 77%
  1 Scopus citations

• Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults

  Esquivel, M. D., Monogue, M. L., Smith, G. S., Finklea, J. D. & Sanders, J. M., Mar 2022, In: Journal of Global Antimicrobial Resistance. 28, p. 67-70 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • T 91825 100%
  • Vancomycin 64%
  • Cystic Fibrosis 59%
  • Methicillin-Resistant Staphylococcus aureus 41%
  • Lung 16%
  2 Scopus citations

• "The Early Beta-Lactam Catches the Germ": Empiric Antimicrobial Sequence in Bloodstream Infections

  Cutrell, J. B. & Sanders, J. M., Jul 1 2022, In: Clinical Infectious Diseases. 75, 1, p. 105-106 2 p.

  Research output: Contribution to journal › Editorial › peer-review
• 2021

  Bronchoalveolar Lavage Gram Stains for Early Bacterial Identification in Pneumonia: Should They Stay or Should They Go?

  Klimko, C. V., Sanders, J. M., Monogue, M. L., Tilahun, B. A., Arasaratnam, R. J., Reisch, J. S. & Johns, M. L., Aug 2 2021, In: Critical Care Explorations. 3, 8, p. E0501

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Gram's stain 100%
  • Bronchoalveolar Lavage 85%
  • Pneumonia 64%
  • Anti-Bacterial Agents 17%
  • Duration of Therapy 12%
  1 Scopus citations

• Surgical Infection Society 2020 Updated Guidelines on the Management of Complicated Skin and Soft Tissue Infections

  Duane, T. M., Huston, J. M., Collom, M., Beyer, A., Parli, S., Buckman, S., Shapiro, M., Mcdonald, A., Diaz, J., Tessier, J. M. & Sanders, J., May 2021, In: Surgical Infections. 22, 4, p. 383-399 17 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Soft Tissue Infections 100%
  • Guidelines 53%
  • Skin 45%
  • Infections 39%
  • Abscess 30%
  30 Scopus citations

• Tedizolid vs linezolid for the treatment of nontuberculous mycobacteria infections in solid organ transplant recipients

  Poon, Y. K., La Hoz, R. M., Hynan, L. S., Sanders, J. & Monogue, M. L., Apr 1 2021, In: Open Forum Infectious Diseases. 8, 4

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • tedizolid 100%
  • Nontuberculous Mycobacterium Infections 86%
  • Linezolid 72%
  • Transplant Recipients 52%
  • Transplants 35%
  18 Scopus citations

• Therapeutic Options for Coronavirus Disease 2019 (COVID-19): Where Are We Now?

  Bae, E. Y., Sanders, J. M., Johns, M. L., Lin, K., Ortwine, J. K., Wei, W., Mang, N. S. & Cutrell, J. B., Dec 2021, In: Current Infectious Disease Reports. 23, 12, 28.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Coronavirus 100%
  • Medication Therapy Management 29%
  • Pandemics 21%
  • Antimicrobial Stewardship 13%
  • Therapeutics 13%
  5 Scopus citations

• The role of tazobactam-based combinations for the management of infections due to extended-spectrum β-lactamase-producing Enterobacterales: Insights from the Society of Infectious Diseases Pharmacists

  Monogue, M. L., Heil, E. L., Aitken, S. L. & Pogue, J. M., Oct 2021, In: Pharmacotherapy. 41, 10, p. 864-880 17 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  • Tazobactam 100%
  • Pharmacists 62%
  • tazobactam drug combination ceftolozane 54%
  • Communicable Diseases 54%
  • Tazobactam Drug Combination Piperacillin 41%
  2 Scopus citations
• 2020

  Minimal Cerebrospinal Fluid Concentration of Miltefosine despite Therapeutic Plasma Levels during the Treatment of Amebic Encephalitis

  Monogue, M. L., Watson, D., Alexander, J. S., Cavuoti, D., Doyle, L. M., Wang, M. Z. & Prokesch, B. C., 2020, In: Antimicrobial agents and chemotherapy. 64, 1, e01127-19.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • miltefosine 100%
  • Encephalitis 70%
  • Cerebrospinal Fluid 57%
  • Acanthamoeba 46%
  • Leishmaniasis 12%
  6 Scopus citations

• Necrotizing Soft Tissue Infections: A Focused Review of Pathophysiology, Diagnosis, Operative Management, Antimicrobial Therapy, and Pediatrics

  Tessier, J. M., Sanders, J., Sartelli, M., Ulrych, J., De Simone, B., Grabowski, J., Buckman, S. & Duane, T. M., Mar 2020, In: Surgical Infections. 21, 2, p. 81-93 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Soft Tissue Infections 100%
  • Necrotizing Fasciitis 73%
  • Pediatrics 53%
  • Disease Eradication 38%
  • North America 29%
  17 Scopus citations

• Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review

  Sanders, J. M., Monogue, M. L., Jodlowski, T. Z. & Cutrell, J. B., May 12 2020, In: JAMA - Journal of the American Medical Association. 323, 18, p. 1824-1836 13 p.

  Research output: Contribution to journal › Review article › peer-review

  • Coronavirus 100%
  • Severe Acute Respiratory Syndrome 51%
  • GS-5734 42%
  • Pandemics 42%
  • Oseltamivir 13%
  1993 Scopus citations
• 2019

  Drugs in tuberculosis and leprosy

  Ramanathan, M. R., Howell, C. K. & Sanders, J. M., 2019, A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Ray, S. D. (ed.). Elsevier B.V., p. 321-338 18 p. (Side Effects of Drugs Annual; vol. 41).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Leprosy 100%
  • Terizidone 97%
  • Bedaquiline 83%
  • Clofazimine 75%
  • Tuberculosis 71%
  3 Scopus citations

• In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Multidrug-Resistant Pseudomonas aeruginosa in the Neutropenic Murine Thigh Infection Model

  Monogue, M. L., Tabor-Rennie, J., Abdelraouf, K. & Nicolau, D. P., 2019, In: Antimicrobial agents and chemotherapy. 63, 7, e00233-19.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • WCK 5222 100%
  • Pseudomonas aeruginosa 42%
  • Thigh 37%
  • Infections 21%
  • zidebactam 20%
  28 Scopus citations

• Pharmacokinetics-pharmacodynamics of β-lactamase inhibitors: are we missing the target?

  Monogue, M. L. & Nicolau, D. P., 2019, In: Expert Review of Anti-Infective Therapy. 17, 8, p. 571-582 12 p.

  Research output: Contribution to journal › Review article › peer-review

  • Pharmacokinetics 100%
  • Health Services Needs and Demand 36%
  • Expert Testimony 34%
  • Gram-Negative Bacteria 33%
  • Bacteria 22%
  16 Scopus citations